Pharmaceutical suspension formulation

Details Pharmaceutical suspension formulation Pharmaceutical suspension formulation

1997-03-03

1998-07-07

Kulkosky, Peter F.

Drug, bio-affecting and body treating compositions

Designated organic nonactive ingredient containing other...

Carbohydrate or lignin, or derivative

514314, A61K 4708, A61K 4736

Patent

active

057769877

ABSTRACT:
A pharmaceutical suspension formulation comprising 0.1 to 40% by weight ##STR1## as the active ingredient; 0.1 to 40% by weight Transcutol; 0.1-99% by weight starch; 0-40% by weight polyethylene glycol, NaOH and water,

REFERENCES:
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5420141 (1995-05-01), Boigegrain et al.
patent: 5633009 (1997-05-01), Kenealy et al.
Marsh et al Journal of the Assoc. Off. Anal. Chem. vol. 50, No. 2 1967 pp. 457-462.

Affiliated with

Also associated with

Rating

Pharmaceutical suspension formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical suspension formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical suspension formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1206584